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Introduction: The granaticins are members of the benzoisochromanequinone 
class of aromatic polyketides, the best known member of which is actinorhodin 
made by Sfrepfomyces coelicolor A3(2). Genetic analysis of this class of 
compounds has played a major role in the development of hypotheses about 
the way in which aromatic polyketide synthases (PKSs) control product 
structure. Although the granaticin nascent polyketide is identical to that of 
actinorhodin, post-PKS steps involve different pyran-ring stereochemistry and 
glycosylation. Comparison of the complete gene clusters for the two 
metabolites is therefore of great interest. 
Results: The entire granaticin gene cluster (the gra cluster) from 
Sfrepfomyces violaceoruber Tii22 was cloned on either of two overlapping 
cosmids and expressed in the heterologous host, Sfrepfomyces coelicolor 
A3(2), strain CH999. Chemical analysis of the recombinant strains 
demonstrated production of granaticin, granaticin B, dihydrogranaticin and 
dihydrogranaticin B, which are the four known metabolites of S. violaceoruber. 
Analysis of the complete 39,250 base pair sequence of the insert of one of the 
cosmids, pOJ466-22-24, revealed 37 complete open reading frames (ORFs), 
15 of which resemble ORFs from the act (actinorhodin) gene cluster of 
S. coelicolor A3(2). Among the rest, nine resemble ORFs potentially involved in 
deoxysugar metabolism from Sfrepfomyces spp. and other bacteria, and six 
resemble regulatory ORFs. 
Conclusions: On the basis of these resemblances, putative functional 
assignments of the products of most of the newly discovered ORFs were made, 
including those of genes involved in the PKS and tailoring steps in the 
biosynthesis of the granaticin aglycone, steps in the deoxy sugar pathway, and 
putative regulatory and export functions. 
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Introduction 
Granaticin and the related metabolites dihydrogra- 
naticin, granaticin B and dihydrogranaticin B (Figure l), 
made by Streptomyces violaceoruber Tii2’2, are members of 
a class of Streptomyces aromatic polyketide antibiotics 
known as the benzoisochromanequinones (BIQs), the 
best known member being actinorhodin (Figure 1) pro- 
duced by Streptomyces coelicolor A3(2). Extensive genetic 
analysis of actinorhodin biosynthesis revealed a cluster 
of 22 structural, resistance and regulatory genes (the act 
genes) for antibiotic biosynthesis and export [l-6]. Less 
extensive genetic studies have been made on other 
BIQ antibiotics, including frenolicin [7], griseusin [8] 
and kalafungin [9]. 
The carbocyclic skeleton of the BIQs is assembled by 
successive decarboxylative condensations of malonyl 
residues to give a polyketide carbon chain, which is sub- 
sequently reduced and cyclised. These early steps in BIQ 
biosynthesis are catalysed by the polyketide synthase 
(PKS) and the corresponding PKS subunit genes are 
highly conserved throughout the BIQ clusters. A primary 
stimulus to the study of BIQ genetics has been use of the 
PKS genes to understand the ‘programming’ rules that 
control carbon chain length and the patterns of ketore- 
duction and cyclisation of such aromatic polyketides. 
These studies (e.g. [lO,ll]) led to conclusions about the 
roles of the different PKS subunits - ketosynthase, 
chain length factor, acyl carrier protein, ketoreductase, 
aromatase and cyclase - in the programming choices, 
and to application of these programming ‘rules’ to synthe- 
sise novel ‘unnatural natural products’ to order [ll]. Isola- 
tion and sequencing of the granaticin PKS genes [12] 
played a significant role in this research [13-151. 
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Figure 1 
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Structures of the granaticins, actinorhodin and 
a hypothetical intermediate in the biosynthesis 
of both antibiotics. 
Control of the post-PKS (‘tailoring’) steps that give each 
BIQ its final structure and biological activity has been 
much less studied. Granaticin provides two particularly 
interesting dimensions to such research. One question 
concerns the stereochemistry of the pyran ring of the BIQ 
antibiotics. The two chiral centres (C-3 and C-15) are 
always trans in respect of the two hydrogen atoms in all 
natural BIQs, but can be either 3R, 15X’, as in actinorhodin, 
or 3S, 15R, as in granaticin (Figure 1). Two putative 
reductases responsible for establishing the chirality at 
these two carbon atoms in actinorhodin have been sug- 
gested to be the products of two of the act genes [6]; what 
are the roles of the corresponding genes from the gra- 
naticin pathway? The second question concerns the 
2,6-dideoxyhexose moiety attached to the BIQ chro- 
mophore via two carbon-carbon bonds at C-9 and C-10, as 
well as the second deoxy-sugar (a 2,3,6 trideoxyhexose, 
L-rhodinose) attached to the first sugar by a conventional 
glycosidic bond. Carbon origins and some stereochemical 
features of sugar biosynthesis and attachment were eluci- 
dated by feeding 13C-labelled acetate and 14C/3H-labelled 
glucose [16], and two relevant genes were identified [17]; 
what further ‘sugar genes’ exist? Here, we describe the 
complete DNA sequence of a gene cluster that was 
proven, by expression in a heterologous host, to be suffi- 
cient for biosynthesis of the granaticin metabolites. On the 
basis of this experimental evidence, we could begin to 
answer these questions. 
Results 
Expression of the granaticin gene cluster in S. coe/ico/orA3(2) 
S. coelicolor CH999, which lacks the actinorhodin gene 
cluster, produces no blue or purple pigments. In contrast, 
transconjugants of CH999 containing cosmids pOJ446-22- 
24 or pOJ446-Z-16, which carry overlapping inserts of 
S. vZolaceorz&r DNA [17], produced purple and purple- 
brown pigments, respectively. Analysis using thin layer 
chromatography (TLC) identified the pigments as dihy- 
drogranaticin, dihydrogranaticin B, and the corresponding 
lactone forms, granaticin and granaticin B, the four prod- 
ucts of S. violaceomber Tii22. High performance liquid 
chromatography (HPLC) analysis of crude extracts 
(Figure 2) showed that CH999/pOJ466-22-24 yielded 
dihydrogranaticin as -50% of total pigments, with 45% of 
dihydrogranaticin B and only small quantities of granaticin 
and granaticin B. In contrast, pOJ466-22-16 yielded -28% 
granaticin and 52% granaticin B, with smaller quantities of 
the dihydro forms; these proportions were similar to those 
produced by S. violateorder Tii22 itself (38% granaticin 
and 42% granaticin B). All of the genetic information 
required for S. coe&zodor CH999 to produce the four end 
products of the granaticin pathway therefore lies on the 
overlap between pOJ466-22-24 and pOJ466-Z-16. 
Sequence analysis of cosmid pOJ446-22-24 
The complete sequence of the insert in cosmid pOJ446- 
22-24 (39,250 base pairs) was compiled using the sequence 
Figure 2 
HPLC traces of granaticins produced by 
S. coelicolor A3(2) strain CH999 carrying 
(a) pOJ446-22-24 or (b) pOJ446-22-16. For 
comparison, (c) S. violaceoruberTii22 (the 
original granaticin producer) and 
(d) CH999/pOJ446 (vector only) are shown. 
HPLC is described in the Materials and 
methods section. The retention times are as 
follows: dihydrogranaticin, 7.25 min; 
granaticin, 9.58 min; dihydrogranaticin B, 
13.26 min; granaticin B, 15.87 min. 
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of the PKS region (B13 and parts of B8 and B5; Figure 3) 
and a segment (B32 and B24) containing, among others, 
two genes involved in early steps in the 2,6-dideoxyhexose 
pathway, both reported previously [l&17] (a few parts of 
these sequences were amended), together with the new 
sequence for the rest of the cosmid insert. Probable 
protein-coding regions were identified by the FRAME 
program [18], which makes use of a strong bias towards a G 
or C in the third position of Streptomyces codons, by identi- 
fication of plausible ribosome-binding sites [19], and by 
alignment of deduced protein sequences with homologous 
sequences in the databases. The deduced open reading 
frames (ORFs) were designated as shown in Figure 3, 
retaining ORFs l-6 for the PKS genes [12] and numbering 
the others consecutively from left to right. We identified 
37 putative complete ORFs (Table 1) and a truncated 
ORF at either end, together with a putative tRNA gene 
and several inverted repeats in intergenic regions. 
Assignment of the PKS and cyclisation ORFs 
As described previously [12], gra ORFs l-5, encoding the 
minimal gra PKS (ketosynthase, chain length factor and 
acyl carrier protein), aromatase and ketoreductase, lie in 
the same order as in the act cluster: downstream of the gra- 
ORFS ketoreductase gene is a second act111 homologue 
(gra-ORFb), which might function together with ORFS to 
control C-9 ketoreduction as suggested previously [l&13], 
or, alternatively, might be involved in a tailoring step (see 
the Discussion section). The final gene expected to be 
required for assembly of the BIQ carbon skeleton, namely 
the cyclase (the homologue of the a&V gene product) 
[ZO], which would catalyse aldol condensation between 
C-5 and C-14 to close the second ring after the first ring 
has been dehydrated by the aromatase, was identified in 
the present study and is clearlygra-ORF33. 
Assignment of ORFs for post-PKS tailoring steps in 
aglycone biosynthesis 
Apart from the stereochemistry of the pyran ring, which is 
3S, 15R for granaticin in contrast to 3R, 15s for acti- 
norhodin, the structure of the granaticin aglycone is identi- 
cal to that of the actinorhodin half-molecule. Homologues 
of many of the ‘tailoring’ genes identified previously in the 
act cluster of S. coelicolor (shown in Figure 3, top), whose 
products convert the biosynthetic intermediate (Figure 1) 
generated by the minimal PKS, ketoreductase, aromatase 
and cyclase to actinorhodin, might therefore be expected to 
occur in the gra cluster. From left to right in Figure 3, the 
proposed functions of the act tailoring genes are as follows. 
actVI-ORFA is a member of a family of genes found in the 
gene clusters for Streptorr2yces aromatic polyketides, the 
founder member being fren-ORFX from the frenolicin 
cluster of S. roseofulvas [7] and including mtmX from the 
mithramycin cluster of S. arg&zcezls [Zl], and dpsH from 
the daunorubicin clusters of S. peucetizls [ZZ] and Strepto- 
myces sp. strain (2.5 [23]. The function of a&I-ORFA is 
unclear: its disruption reduced, but did not abolish, 
pigment production [6]. It has recently been suggested 
that mtmX and dpsH might encode polyketide cyclases 
[21,22], but without firm evidence. gm-ORF31 is clearly 
the homologue of a&I-ORFA. 
The other uctV1 genes - ORFs 1,2,3 and 4 - are candi- 
dates for controlling pyran-ring formation [6]: a&I-ORFl 
and actVI-ORFZ were postulated to encode reductases for 
C-3 and C-15, respectively, a&I-ORF3 (disruption of 
which caused only a delayed blue pigmentation upon 
ammonia fuming) might encode a dehydratase that assists 
pyran-ring formation, whereas actVI-ORF4 appeared to be 
a ‘silent’ homologue of a&I-ORFZ. In the gra cluster, 
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Figure 3 
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Organisation of the gra cluster of S. violaceoruber T022 and for cosmid pOJ446-22-24, and are not present on the chromosome of 
comparison, the act cluster of S. coe/ico/orA3(2). Restriction sites: B, S. violaceoruber Tii22. KS, ketosynthase; CLF, chain length factor; ACP, 
BarnHI; SP, Spel; RV, EcoRV. The sites in parentheses are derived from acyl carrier protein; KR, ketoreductase; ARO, aromatase; CYC, cyclase. 
ORF18 is a clear homologue of a&I-ORF3, but no homo- 
logues of the key genes a&I-ORFl and actVI-ORFZ/4 are 
seen, suggesting that the C-3 and C-15 reductions in gra- 
naticin biosynthesis are catalysed by enzymes that do not 
resemble, in sequence, the corresponding actinorhodin 
enzymes (see the Discussion section). 
At least some of the tailoring genes in the a&A region 
have been implicated in introducing oxygen at C-6 and 
C-8 of the BIQ chromophore. a&A-ORF6 was postu- 
lated, by homology with tcmH in the tetracenomycin 
cluster of S. glaucescens that encodes a monooxygenase 
[24] and studies of the expressed a&A-ORF6 protein 
[25], to be responsible for oxidation at C-6 in acti- 
norhod.in biosynthesis [6]. Evidence that at least some of 
the other a&A tailoring ORFs are involved in C-8 
hydroxylation includes the following: ‘classical’ a&A 
mutants, which accumulate an unhydroxylated interme- 
diate [26], were mapped mostly in actVA-ORF5, with 
some probably in actVA-ORF3 and a&A-ORF4 [Z]; 
recombinants carrying the a&A region converted 
medermycin (lacking C-S hydroxylation) to the C-S 
hydroxylated mederrhodin [27]; and the a&A-ORFS 
product resembles a known phenol hydroxylase (Acces- 
sion number U17960). A clear homologue of a&A-ORF5 
was found in the gra cluster @a-ORFZl), but, surpris- 
ingly, there was no a&A-ORFh homologue. In addition, 
both gra-ORF28 and gra-ORFSO resemble a&A-ORF3 
to a similar degree, but no homologues of a&A-ORFZ or 
a&A-ORF4 were seen. This suggests that oxidation/ 
hydroxylation reactions in granaticin biosynthesis might 
differ significantly from those in actinorhodin biosynthe- 
sis (see the Discussion section). 
The final act tailoring gene, a&B, encodes a flavin 
mononucleotide (FMN) : NADH oxidoreductase [as], 
which is likely to be involved either in hydroxylation at 
C-8 (a blocked mutant accumulates kalafungin, with C-6 
but not C-8 hydroxylation [26]), or in dimerisation via 
C-10 (kalafungin is a monomeric BIQ). gra-ORF34 is a 
clear homologue of a&B, at first sight perhaps favouring 
the idea that its role is in C-8 hydroxylation, because the 
Research Paper Granaticin biosynthetic gene cluster lchinose et al. 651 
Table 1 
Deduced functions of the open reading frames. 
HomoloQue 
ORF 
Putative 
functional 
category 
7 Regulation 
8 Unknown 
9 Regulation 
10 Regulation 
11 Regulation 
12 Unknown 
13 Unknown 
14 Sugar 
15 Export 
16 Sugar 
17 Sugar 
18 Tailoring 
19 Regulation ? 
20 Regulation 
21 Tailoring 
22 Sugar 
23 Sugar 
24 Unknown 
25 Sugar 
26 Sugar 
27 Sugar 
28 Tailoring ? 
29 Sugar ? 
6 PKS ? 
5 PKS 
1 PKS 
2 PKS 
3 PKS 
4 PKS 
30 Tailoring ? 
31 Tailoring ? 
32 Unknown 
33 Tailoring 
34 Tailoring 
35 Unknown 
36 Unknown 
37 Regulation 
Gene Deduced role 
SMIID 
(O/o) of product Origin Reference 
pkaA 
act/l-4 
deglJ 
degS 
Serine-threonine protein kinase 45138 
Pathway-specific transcriptional activator 46140 
Response regulator of two-component system 57134 
Sensor kinase of two-component system 45/l 9 
dnrS Glycosyl transferase 52126 
act/l-2 Transmembrane protein 57130 
s&D dTDP-1 -glucose synthase 70151 
strf dTDP-glucose-4,6-dehydratase 76161 
actVl-3 Cyclase-dehydratase ? 52136 
Disulphide bond-forming protein ? - 
soxR Transcriptional activator in redox control 72156 
actVA-5 Hydroxylase 69153 
dnmV dTDP-4-keto-6-deoxyhexose reductase 51144 
rfbH (ascC) CDP-4-keto-6-deoxyglucose-3-dehydratase (El) 71153 
strM 
- 
52146 dTDP-4-keto-6-deoxyglucose-3, 5-epimerase 
in streptomycin biosynthesis 
Rhodomycin biosynthesis 
dTDP-4-keto-6-deoxyglucose-2, 3-dehydratase 
Unknown 
FMN-dependent monooxygenase 
in lincomycin biosynthesis ? 
Keto reductase (KR) 
Keto reductase for C-9 (KR) 
Keto-acyl synthase (KS) 
Chain length factor (CLF) 
Acyl carrier protein (ACP) 
First ring aromatisation (ARO) 
Unknown 
Unknown 
rdmF 
dnmT 
a&VA-3 
ImbY 
actlll 
actlll 
act/-l 
actl-2 
actl-3 
actVll 
actVA-3 
actVl-A 
a&IV 
actVB 
- 
nshA 
Second ring cyclisation (CYC) 
FMN : NADH oxidoreductase 
Transcriptional activator 
65147 S. purpurescens 
53146 S. peucetius 
46141 S. coelicolor 
48129 S. lincolnensis 
47142 S. coelicolor 
75171 S. coelicolor 
82176 S. coelicolor 
68161 S. coelicolor 
76166 S. coelicolor 
58153 S. coelicolor 
47142 S. coelicolor 
64158 S. coelicolor 
71155 S. coelicolor 
56134 S. coelicolor 
82170 
S. coelicolor 
S. coelicolor 
B. subtilis 
B. subtilis 
S. peucetius 
S. coelicolor 
S. griseus 
S. griseus 
S. coelicolor 
E. coli 
S. coelicolor 
S. peucetius 
Y. pseudotuberculosis 
S. griseus 
S. actuosus 
Lb61 
[41 
[451 
[451 
[341 
141 
1291 
[301 
[61 
1421 
El 
[=I 
[=I 
[301 
[371 
[391 
El 
[401 
[31 
[31 
[51 
[51 
[51 
[51 
P-1 
El 
[51 
151 
[471 
Nucleotide 
accession 
number 
D86821 
M64683 
M23558 
M23558 
L47164 
M64683 
YOO459 
X62567 
X62373 
M60111 
X58833 
AF006633 
LO1 777 
X62567 
u10405 
U77891 
X58833 
X791 46 
Ml9536 
Ml9536 
X63449 
X63449 
X63449 
X63449 
X58833 
X62373 
X63449 
X63449 
u75434 
? indicates a very tentative assignment of function. Y. pseudotuberculosis, Yersinia pseudotuberculosis. B. subtilis, Bacillus subtilis. SM/ID, % 
similaritylidentity of amino-acid sequences. 
granaticin chromophore is not a dimer. It could be that 
sugar attachment in granaticin biosynthesis requires a 
similar redox change at C-10 as dimerisation in the 
biosynthesis of making actinorhodin, however (see the 
Discussion section). 
Assignment of sugar ORFs 
Bechthold et al. [ 171 had clearly recognised two gra ORFs - 
now renamed ORF16 and ORF17 - as homologues of the 
S. griseus strD [29] and strE [30], respectively. The products 
of these streptomycin biosynthetic genes [31], dTDP-l- 
glucose synthase (strD) and dTDP-glucose-4,6-dehydratase 
(ibE), catalyse the first two steps in deoxyhexose biosyn- 
thesis from glucose-l-phosphate. Expression of gra-ORFl6 
in EscAeric~Za coli [17] confirmed production of dTDP-C 
keto-6-deoxyglucose, the precursor of the two deoxysugars 
(dTDP-4-keto-‘2,6-dideoxyglucose and I,-rhodinose) that 
are components of granaticin and its related metabolites 
(Figure 1). 
Database comparisons showed that gmORF25 would 
encode a similar protein to the product of strM [30] and 
rmK’ (Accession number UO9876), dTDP-4-keto-h- 
deoxyglucose-3,5-epimerase. 
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gra-ORF23 is a homologue of as& ($bH) [32], which 
encodes the key enzyme CDP-4-keto-6-deoxyglucose-3- 
dehydratase (E,) in the 3,6-dideoxyhexose pathway in 
Yersinia pseudotuberculosis. E, is a typical pyridoxamine 
5’-phosphate (PMP)-dependent enzyme, with a conserved 
histidine residue (His220) at the active site, which 
abstracts a C-4’ proton from a PMP-substrate adduct [33]. 
Another feature of E, is a series of cysteine residues com- 
monly found in iron-sulphur-containing enzymes. The 
ORF23 protein has both features, as well as high end-to- 
end homology with the ascC product, suggesting that the 
ORF23 product depends on PMP, unlike the other ascC 
($bH) homologues found in streptomycetes so far, includ- 
ing dnrJ (Accession number M80237 from S. peucetizcs, and 
others [33], which have a conserved lysine residue instead 
of a histidine residue, indicating their dependence on 
pyridoxal .5’-phosphate (PLP). 
gra-ORF14, reported previously [17], was extended by 
29 amino acids at the carboxyl terminus after making 
some sequence corrections. It resembles sugar trans- 
ferases from bacteria, including DnrS [34] from 
S. peucetius and others (Accession numbers M74717, 
U40458, 222577 and A25110). The homologous regions 
[34] among these proteins [3.5] are in the amino terminus 
(2HIXMXXIAXXGHVNPXXXXXRXLXARGHRVXXA- 
XXPXXXDXVXXXG47; residues in italics are highly con- 
served; X indicates a variable residue; residue numbers 
are those in DnrS; single-letter amino-acid code is used) 
and carboxyl terminus (296LXXLPXNVXVXXWXPXXA- 
ILXXXXXFIIXHGAXXXXXLAXXXPXIAXPXAXDQF- 
XNADXLXXLGXXXXL365). The gra-ORF14 product 
(343 amino acids) showed 3246% identity with these pro- 
teins, with a substantial number of gaps in the alignment. 
The conserved residues were reasonably matched for the 
carboxyl terminus, but not for the amino terminus. There is 
another ATG codon a further 117 base pairs upstream from 
the putative gra-ORF14 start codon (ATG), which would 
add an extra 39 amino acids to the product (382 amino acids 
in total). The extended region includes the sequence 
a6NAGHEVIVGA35, which is partially identical to the 
amino-terminal motifs of the other members of the family, 
suggesting that the upstream ATG is the true start codon. 
The products of gra-ORFs 22 and 26 resemble putative 
biosynthetic gene products involved in the biosynthesis of 
anthracyclines, including dnmV in S. peucetizls [36], rdmF in 
S. purpurescens [37], and a gene from S. gtieus (Accession 
number X73148); these genes are assumed to be involved 
in deoxyhexose biosynthetic pathways. Nucleotide-binding 
motifs [37,38] were found for both products (ORFZZ: 
11LVLGGSGFVGRHVCAAFLARGWEV34; ORF26: iZLR- 
IGVAGCADIALRRMLPAFAASP35; residues in italics are 
highly conserved). Although the motif from the ORF26 
product is less conserved, it also resembles glucose-fructose 
oxidoreductase from Zymomonas mobiGis (Accession number 
M97379). The gra-ORF22 and ORF26 proteins are 
therefore possible oxidoreductases involved in deoxyhex- 
ose biosynthesis. 
A high degree of similarity (SO-53%) was found for thegra- 
ORF27 product with the genes most probably involved in 
deoxysugar formation for several anthraquinone or 
macrolide antibiotic biosyntheses. The homologues 
include dnmT from the daunorubicin biosynthetic gene 
cluster in S. peucetizls 1391, a similar gene from the dauno- 
mycin biosynthetic cluster in Streptomyces sp. strain C5 
(Accession number U43704), eyBVI from the ery- 
thromycin cluster in S. eyth-aea (Accession numbers 
U77459, Y11199), snoH from the nogalamycin cluster in 
S. nogalater (Accession number AJ224512), and a partially 
sequenced gene (ORF6) in the tylosin gene cluster in 
S. fradiae (Accession number U08223). Because the final 
structures of the deoxysugar moieties are different for the 
different antibiotics, we conclude that the gra-ORFZ7 
gene product probably functions at an early step, most 
likely as a dTDP-4-keto-6-deoxyglucose-2,3-dehydratase 
(see the Discussion section). 
The product of gra-ORF29 resembles that of l’mbY in the 
lincomycin gene cluster of Streptomyces hzcolnensis. The 
lmbY product was reported [40] to resemble (21% similar- 
ity) FMN-dependent a subunits of alkaline monooxyge- 
nase encoded by &A from Xenorhaba’us luminescens 
(Accession number M62917), but the possible function of 
this gene remains unknown. 
Assignment of ORFs putatively involved in regulation or 
antibiotic export 
gra-ORF15, described previously [17], is a homologue of 
a&I-ORFZ, whose product is a putative transmembrane 
protein [4] implicated, by gene disruption studies, in acti- 
norhodin export and possibly coupled to the conversion of 
actinorhodin to the lactone form, y-actinorhodin [ 11. 
Of the newly discovered ORFs, gra-ORF9 is a homologue 
of actII-ORF4 [4], the founder member of a family of 
pathway-specific transcriptional activator genes for antibi- 
otic biosynthetic pathways [41]. The amino-terminal 
regions of this class of proteins (named SARPs, for Strepto- 
myces antibiotic regulatory proteins) contain amino-acid 
motifs that resemble the DNA-binding fold of the OmpR 
class of regulatory proteins. These motifs are well con- 
served in the gra-ORF9 product. The SARPs would inter- 
act with specific sequences, upstream of Streptomyces 
antibiotic biosynthetic genes to ensure that the RNA poly- 
merase engages with the promoter to initiate transcription. 
Wietzorrek and Bibb [41] also described some characteris- 
tic direct repeat sequences in the promoter regions of 
Streptomyces antibiotic biosynthetic genes that are potential 
binding sites for the SARPs. A search for such sequences 
in the gra cluster revealed a tandem array of trimeric 
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repeats with the consensus 5’-CNA (where N is any 
nucleotide), separated by eight nucleotides. This spacing, 
corresponding to one turn of the DNA helix, places each 
repeat on the same face of the DNA, perhaps to allow CO- 
operative binding of several SARP molecules. In all the 
examples in which a putative -10 promoter sequence 
could be recognised (i.e., excluding ORF8), the promoter- 
proximal repeat would be on the opposite side of the 
DNA helix from the conserved T in the -10 region (typi- 
cally 17 nucleotides upstream of it), allowing simultaneous 
binding of the SARPs and the RNA polymerase. 
The product of gra-ORFZO resembles SoxR from E. coli 
[42] which operates, together with the product of the 
divergently transcribed SOXS, to bind to specific highly con- 
served promoter sequences and activate them in response 
to oxidative stress. The product of the gene immediately 
upstream of gra-ORFZO, gra-ORF19 transcribed in the 
same direction, does not resemble SoxS, but contains the 
motif i1CPWCY16 (single-letter amino-acid code), which 
could be regarded as a CXXC motif (where X is any amino 
acid), found in members of the glutaredoxin/thioredoxin 
superfamily of redox sensors [43]. A search of the gra 
sequence for possible SoxR-binding sites revealed two 
convincing candidates in the promoter regions of ORF19 
and ORF15, the latter encoding the putative granaticin- 
resistance protein. The ORF19 gene product, perhaps 
together with that of ORFZO, might therefore modulate 
resistance to granaticin in response to changes in the redox 
potential of the cells; a change in redox state might even 
be a direct consequence of granaticin biosynthesis. 
The products of a further pair of putative regulatory 
genes, gra-ORFll and gra-ORFlO, resemble bacterial 
two-component sensory kinase/response regulator pairs 
[44]; their closest homologues are degS and &gU from 
BacUus subtilis [45]. These putative regulators probably 
play a role in regulating granaticin biosynthesis because 
they lie to the right of gra-ORF9, the very characteristic 
pathway-specific regulatory gene. On the other hand, gra- 
ORF7, whose product resembles that of @aA, a 
serine-threonine protein kinase from S. co&olor [46], 
could well lie outside the gra cluster. The same is likely to 
be true of gra-ORF37, the last complete ORF at the right- 
hand end of pOJ466-Z-24, whose product is similar to 
that of the putative transcriptional activator gene ns4.A 
(‘ORF699’) from S. UCLUOSUS [47]. 
The ‘unknown’ ORFs 
No meaningful similarities were found with comparisons of 
the deduced products of ORFs 8, 12, 13, 24, 32, 3.5 and 36 
or the two incomplete ORFs at either end of the sequence. 
Identification of a tRNA gene and inverted repeats 
A convincing alanine tRNA-like sequence was found 
between ORFs 8 and 9. Eight obvious inverted repeat (IR) 
sequences were also identified, many of them in expected 
positions (see Figure 3). IRl is located downstream of 
tRNA-Ala, and four others (IRZ, IRS, IR6 and IRS) lie 
between the stop codons of convergently transcribed 
ORFs. Two further IRS (IR3 and IR4) lie within a group 
of ORFs with the same orientation. 
Discussion 
The gra PKS genes were originally cloned by homology 
with actinorhodin PKS gene probes [48]. Although S. Go- 
laceoruber TG2 is recalcitrant to plasmid transformation 
(our unpublished observations) granaticin nonproducing 
gene disruptants were made using a (pC31 phage vector 
[48], providing evidence that the cloned genes were 
indeed those for the granaticin PKS. These genes were 
later sequenced [la]. Finding genes apparently involved 
in deoxyhexose biosynthesis within -7 kilobases of the gra 
PKS genes [17] fitted this assignment. The present 
results, in which heterologous expression of the putative 
gra genes on either of the cosmids gave rise to the gra- 
naticin-related metabolites characteristic of S. violaceoruber 
Tii22, dispel any possible doubts about the correct identi- 
fication of the gra gene cluster. 
What are the likely limits of the gra cluster? pOJ446-22-16 
induced biosynthesis of all four of the granaticin metabo- 
lites in similar proportions to those in S. violaceoruber, 
implying that genes lying to the right of the end point of 
the insert in this cosmid (ORFs 35-37) are outside the gra 
cluster. Sequencing of the right-hand terminus of the 
insert showed it to end just inside ORF34 (truncating it by 
11 amino-acid residues at its amino terminus). Because the 
ORF34 product resembles that of an essential gene in acti- 
norhodin biosynthesis (a&B, encoding an FMN : NADH 
oxidoreductase) we presume that this ORF forms part of 
the gra cluster. 
The first gene from the left end of pOJ466-22-24 that is 
recognisably a member of the gra cluster is ORF9, a 
member of the SARP family of pathway-specific activators 
for Streptomyces antibiotic gene clusters [41]. This implies 
that all the genes to the right of gra-ORF9, including the 
putative sensory kinase/response regulator pair encoded 
by ORFs 11 and 10, and the unassigned genes (ORFs 12 
and 13) to their right, play some roles in granaticin biosyn- 
thesis, regulation or export. To the left ofgra-ORF9 lie a 
tRNAALA gene, an unassigned gene (ORF8) and a homo- 
logue of the serine-threonine protein kinase gene pRaA 
(ORF7). Of these, ORF8 is preceded by a convincing run 
of SARP-binding sites, implying a functional relationship 
with the granaticin biosynthetic pathway. There is no 
reason to believe that the pRaA homologue is also involved 
in the pathway. DNA to the left of the terminus of 
pOJ446-22-24 is evidently not needed for the production 
of the four granaticin-related metabolites in S. coelicolor 
A3(2), and so could be regarded as lying outside the gra 
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cluster. Because the recombinant carrying pOJ446-22-16 
has a product profile (Figure 2b) more closely resembling 
that of 5’. viulaceor~ber Tii22 (Figure Zc) than that carrying 
pOJ446-22-24 (Figure Za), however, a gene(s) encoding an 
enzyme(s) that might aid lactonisation of the dihydro 
forms into the corresponding granaticins (though not 
being essential for this) could conceivably lie to the left of 
the terminus of pOJ446-22-24 in an unsequenced segment 
of pOJ446-Z-16. 
The segment from ORF8 to ORF34 consists of 33 genes, 
in contrast to the 22 for the act cluster; this is reasonable 
because granaticin B contains two deoxysugars that are not 
part of the actinorhodin molecule, and, in fact, nine of the 
gra genes are candidates for involvement in deoxyhexose 
metabolism. Based on the direction of transcription of the 
33 putative g9-a genes, the genes would be organised in a 
minimum of 11 transcripts, four of them monocistronic. If 
we assume that IR3 and IR4 also represent transcription 
termination points, the number of transcripts would rise to 
13, and if, as expected, SARP-binding sites identify further 
start points for transcription, it would rise to 17, with eight 
of them monocistronic. Apart from the PKS genes, there is 
only limited clustering of functionally related genes on the 
different transcripts (less than in the act cluster). 
In addition to the SARP gene @a-ORF9) and gra- 
ORF15, the homologue of the actinorhodin export gene 
@II-ORFZ), 13 of the gra genes are likely homologues 
of act genes involved in chain building, cyclisation and 
tailoring steps in the actinorhodin pathway. The earlier 
finding of gra homologues (ORFs 1,2,3,5 and 4, respec- 
tively) for the act minimal PKS genes (actI-ORF1,2,3 for 
ketosynthase, chain length factor and acyl carrier protein), 
ketoreductase (a&II) and aromatase (a&II), and of the 
cyclase (actIV) in the present study (ORF33), is com- 
pletely consistent with the fact that the granaticin biosyn- 
thetic pathway would proceed via identical steps to that 
of actinorhodin as far as the putative biosynthetic inter- 
mediate in Figure 1. Although, even beyond formation of 
this dicyclic intermediate, biosynthesis of the acti- 
norhodin and granaticin chromophores would be 
expected to proceed by similar pathways (except for the 
stereochemical course of the C-3 and C-15 reductions for 
actinorhodin catalysed by many of the a&VI and actVAIB 
genes), sequence comparisons suggest more profound dif- 
ferences between the two pathways. 
Of particular interest is the lack of gra homologues for 
a&I-ORFl and a&I-ORF2/4, postulated to encode 
stereospecific reductases for C-3 and C-15 [6]. Although 
there is a precedent for catalytically related enzymes with 
opposite stereospecificities having similar sequences [49], 
there are also examples where the two proteins are ap.par- 
ently unrelated [50], and this is presumably the case for 
the gra gene products. We are now using functional tests to 
seek the equivalents of the enzymes encoded by actVI- 
ORFl and actVI-ORFZ/4 (but with opposite stereochemi- 
cal outcome), focusing initially on unassigned putative 
gene products that either resemble ketoreductases @a- 
ORF6), or carry potential NAD(P)H binding motifs @-a- 
ORF’26). Oxygenation/hydroxylation at C-6 and C-8 could 
also be catalysed differently in the two pathways because, 
although the gra cluster contains homologues of a&A- 
ORF5 @a-ORF21) and a&A- ORF3 (two homologues: 
gra-ORF28 and gra-ORF30), it lacks homologues of a&VA- 
ORFZ, a&A-ORF4 and a&A-ORF6. The gra cluster has 
enough unassigned ORFs to provide alternative proteins 
to catalyse this part of the biosynthetic pathway. 
There is currently much interest in biosynthesis of the 
deoxysugars that decorate many actinomycete secondary 
metabolites and other products of bacteria such as the 
O-antigens of the gram-negative cell surface [51,52]. 
Bechthold et al. [17] assigned, plausibly, gra-ORF16 
(graD) and gra-ORF17 @aE) as the genes for converting 
glucose-l-phosphate to the generally accepted precursor, 
dTDP-4-keto-6-deoxyglucose, but little experimental evi- 
dence is available for mechanistic aspects of deoxyhexose 
biosynthesis in granaticin and granaticin B beyond this 
point [16]. A plausible pathway leading to these sugars is 
shown in Figure 4 [52]. A suggested candidate gene for 
the 2,3-dehydration step (a) is ORF27, which has homo- 
logues in other 2,6-dideoxyhexose biosynthetic gene clus- 
ters. Two ketoreductions, steps (b) and (f), would be 
catalysed by the oxidoreductases encoded by ORFs 26 
and 22. The ORF25 protein is likely to function as an 
epimerase at step (e), like the strM product postulated to 
epimerise the C-5 methyl group in streptomycin biosyn- 
thesis [34]. The discovery of an ascC ($H) homologue 
[36] in the gra cluster (ORF23) is interesting, because all 
the other +H homologues reported in streptomycetes 
[33] are involved in formation of aminosugars, whereas the 
deoxyhexoses of granaticin lack amino groups. CDP-4- 
keto-6-deoxyglucose-3-dehydratase (E,), encoded by ad, 
requires E, (CDP-6-deoxy- 3,4-glucoseen 3-reductase) as a 
catalytic partner in CDP-3,6-deoxyhexose biosynthesis 
[52]. The lack of an E, homologue in the deoxyhexose 
pathways involved in antibiotic production so far studied 
suggests the intriguing possibility [34,52] that an ad 
homologue would encode an aminotransferase depending 
on coenzyme-B6 (PLP). The high degree of similarity 
between the ORF23 product (including the ‘PMP’ motif 
and the iron-sulphur cluster motif [33]) and the as& 
protein might imply that the deoxygenation at steps (c) 
and (d) would proceed in a similar way to that observed in 
the 3,6-dideoxyhexose pathway in Y. pseua’otubercdosis. 
Two glycosylation steps are needed for granaticin B forma- 
tion: (g) + (h), and (i) in Figure 4. Of these, the attachment 
of rhodinose to granaticin to convert it to granaticin B (i) 
would be via a conventional glycosidic bond, whereas 
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Figure 4 
Proposed deoxyhexose pathway involved in the 
biosynthesis of granaticins. Probable 
enzymatically catalysed steps are: 
(a) dehydration, (b) ketoreduction, (c) and 
Cd) C-3 deoxygenation, (e) epimerisation, 
(f) ketoreduction, (g) and (8 glycosidations, 
and (h) intramolecular cyclisation. QO (quinone 
oxidase) and OR (oxidoreductase) are involved 
in the interconversion of the ‘dihydro-’ and 
‘lactone’ forms of the granaticins. 
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attachment of 4-keto-2,6-dideoxyglucose to the aglycone aglycone (ai), which would then undergo cyclisation by an 
to make the granaticins (g + h) involves the formation of intramolecular aldol condensation (a,). This mechanism 
two successive carbon-carbon bonds. Only one clear can- requires recognition of the total structural features of the 
didate (gra-ORF14) for a glycosyltransferase was identi- aglycone by the C-glycosyltransferase in order to account 
fied in the gra cluster. We therefore assign this gene to the for recognition of C-9 as the point of attachment. Route (b) 
transfer of rhodinose to granaticin, and postulate that would involve establishment of the glycosidic bond at C-10 
transfer of 4-keto-2,6-dideoxyglucose to the aglycone pro- by an intermolecular aldol condensation (b,), followed by 
ceeds by one of the routes shown in Figure 5 [16]. Route hydroxylation at C-8 (b,), and then an intramolecular cycli- 
(a) involves C-glycosidation of an 8-hydroxylated BIQ sation (bs) to establish the carbon-carbon bond at C-9. In 
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Dihydrogranaticin Chemistry & Biolog) 
Two possible routes of C-glycosidation in the 
biosynthesis of granaticin [16] corresponding 
to steps (g) and (h) in Figure 5. Route a: 
(a,) glycosyl transfer at C-9 of 8 hydroxy- 
BIQ; (a,) intramolecular aldol condensation 
between C-l 0 and C-4’. Route b: 
(b,) intermolecular aldol condensation 
between C-l 0 and C-4; (b,) hydroxylation at 
C-8 of BIQ; (b,) intramolecular cyclisation 
between C-9 and C-l’. 
this hypothesis, the enzymes involved might well not have 
homologues in the databases and could be the products of 
some of the unassigned gra ORFs. Note also that the a&B 
homologue @a-ORF34) could play a role in establishing 
the appropriate redox charge at C-10 (perhaps analogous to 
that in actinorhodin biosynthesis to facilitate dimerisation), 
and that there could well be associated differences in the 
mechanism of C-8 (and perhaps C-6) hydroxylation, 
accounting for the observed differences in the assignments 
of genes for these functions between the actinorhodin and 
granaticin clusters. 
Significance 
The granaticin &-a> biosynthetic gene cluster is only the 
second example of a complete cluster of genes for biosyn- 
thesis of the benzoisochromanequinone antibiotics, 
which have played such a significant part in the estab- 
lishment of the concept of hybrid antibiotic production 
1271 and its extension into combinatorial biosynthesis 
[Ill. Comparisons of the actinorhodin (act) and gra gene 
sets have confirmed or revealed expected similarities in 
the polyketide synthase (PKS) and immediate post-PKS 
enzymes, but have suggested significant differences in 
the tailoring steps involved in pyran-ring formation and 
the hydroxylation reactions, only some of which might 
have been predicted. In addition, the gra gene cluster has 
provided further examples of genes for the deoxysugar 
biosynthetic and transfer reactions that are so crucial for 
biological activity of a huge range of natural products. A 
plausible mechanism is shown for the highly unusual 
C-glycosidation found in the granaticin metabolites. 
Materials and methods 
Bacterial strains, plasmids, culture conditions and DNA 
manipulations 
pOJ446-22-16 and pOJ446-22-24 [17], derivatives of cosmid pOJ446 
[53], harbour inserts of S. violaceoruber T022 genomic DNA. S. coeli- 
co/or A3(2) CH999 [15] (proA7, argA7, redEGO, act::ermE SCPl-, 
SCP2-) lacks the whole of the actinorhodin (act) biosynthetic gene 
cluster (except for a&/I-ORFA: [6]). pBluescript SK-‘+ (PBS-SK-‘+) 
was obtained from Stratagene. Genetic manipulations and culture con- 
ditions for Sfrepfomyces were as described previously [54]. SFM 
medium for Sfreptomyces was as described previously [55]. General 
DNA manipulations were according to standard procedures f.561. 
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Cosmids pOJ446-22-16 and pOJ446-22-24 were introduced into 
strain CH999 by conjugation from E. co/i [57] on SFM plates; 
transconjugants were selected by overlaying plates with 1 ml of 
apramycin sulphate (1 mglml in water) and nalidixic acid (0.5 mglml). 
Purification of granaticins 
Transconjugants of CH999 containing pOJ446-22-24 or pOJ446-22. 
16 were grown as confluent lawns each on ten R5 agar plates [54] 
containing 50 pg/ml apramycin sulphate. After 6 days of growth at 
30°C the culture medium was cut up and extracted with 1 I ethyl 
acetate/methanol/acetic acid (80/20/5) in three portions. The com- 
bined extracts were evaporated to dryness and the residual acetic acid 
was stripped with toluene. The crude extract was dissolved in a 
minimum volume of methanol, centrifuged to remove residual agar, and 
evaporated to dryness. The extract was then dissolved in 40 ml ace- 
tonitrile and filtered, and the pigments were separated on C-l 8 reverse 
phase silica gel (YMC gel ODSA, 120A, l-230/70 mesh) by flash 
column chromatography with methanol/l% acetic acid (SO/SO) as 
eluent. Fractions were pooled, concentrated in vacua, and partitioned 
between dilute acetic acid and chloroform. The chloroform layer was 
dried over Na,SO, and evaporated to dryness. Residual acetic acid 
was stripped with toluene. 
Chemical analysis of granaficin 
Analytical TLC was performed on 0.2 mm silica gel plates (Kieselgel 60 
F sa4, Merck) precoated with 0.5N oxalic acid as described [58]. The 
solvent was chloroform/ethyl acetate (60/40). R, values for granaticin 
(0.25), dihydrogranaticin (0.20), granaticin B (0.14) and dihydrogra- 
naticin B (0.12) correspond to those of Snipes et al. [581. 
An Econosil C-l 8-5U column (5 urn, 250 x 4.6 mm, Alltech) was used 
for analytical HPLC of purified compounds and crude extracts. 
Samples were purified over a C-l 8 adsorption column (Bakerbond) by 
elution with acetonitrile and applied to the HPLC column (20 ~1); the 
chromatogram was developed (O-8 min, 1% acetic acid/acetonitrile 
65:35, 8-30 min 60:40) at room temperature. The flow rate was 
1 ml/min and the adsorbance at 500 nm of the effluent was recorded. 
Retention times were as follows: dihydrogranaticin, 7.25 min; gra- 
naticin, 9.58 min; dihydrogranaticin B, 13.26 min; granaticin B, 
15.87 min. Purified compounds and granaticin isolated previously [58] 
were used as standards for coinjection with crude extracts. 
Because of the poor solubility of dihydrogranaticin in CHCI, the methyl 
ester was prepared in quantitative yield for identification by NMR in 
CDCI,. Dihydrogranaticin (50 mg) was dissolved in anhydrous 
methanol (7 ml) and stirred under argon at room temperature; 
trimethylchlorosilane (0.7 ml) was added slowly from a syringe. After 
2 h the mixture was poured into 300 ml ice water and stirred immedi- 
ately. Dihydrogranaticin methyl ester was extracted with CHCI, and the 
organic layer dried over Na,SO,, filtered and evaporated to dryness. 
NMR data were recorded in CDCI, on a Bruker AF300 instrument at 
300 MHz for ‘H-NMR and at 75 MHz for i3C-NMR. Purified com- 
pounds gave NMR data consistent with published values for dihydro- 
granaticin methyl ester [16,591, dihydrogranaticin B [601 and ‘H-NMR 
of granaticin B [60]. 13C-NMR signals (ppm) of granaticin B were 
assigned by comparison to dihydrogranaticin [59] and dihydrogra- 
naticin B [60] as follows: Cl -170.4, C2-37.0, C3-66.2, C4-68.8, C5- 
139.7, C6-176.7, C7-110.3, C8-166.5, CS-144.6, ClO-130.9, 
Cl 1-167.9, Cl 2-1 11.5, C13-174.1, C14-145.8, C15-67.0, C16-18.3, 
Cl 7-61.6, C18-35.1, C19-67.3, C20-78.8, C21-72.7, C22-16.9, L- 
rhodinose moiety: Cl’-95.0, C2’-25.4, C3’-23.5, C4’-75.5*, C5’-66.9*, 
C6’-17.1 (* can be reversed). 
Negative ion electrospray mass spectra for determination of molecular 
mass (M-l) were recorded with a Fisons VG Quattro II mass spectrom- 
eter. Molpeaks were consistent with expected molecular masses for 
granaticin (M444), dihydrogranaticin (M446), granaticin B (M558) and 
dihydrogranaticin B (M560). 
DNA sequencing 
Sequencing was on single-stranded (rescued using M13K07 helper 
phage) or double-stranded plasmid DNA (PBS-SK-‘+). Sequencing 
was performed manually with the TaqTrack@ system (Promega) or the 
Sequenase version 2.0 DNA sequencing kit (United States Biochemi- 
cals). Alternatively, sequencing was carried out on an automated DNA 
sequencer model 4000L (LI-COR Inc., Neb) with the Therm0 Seque- 
naseTM cycle sequencing kit (Amersham). Subclones 828, 82, 835, 
830, B44, B40 and B9 were sequenced for us by Lark Sequencing 
Technologies Inc., Houston, Texas and DB211 L, DB211 R and BKl by 
Nigel Hartley at the John lnnes Centre, Norwich, UK. DB210, DB211 
(part), B32 (part), 830 (part), B9 (part), B40, B8 (part), B13 (part), B5 
and BKI (part) by K.I. at the University of Tokyo; B32 (part) and 624 
(part) by A.B. at the University of Tubingen. B40 and B44 were 
sequenced by D.T. at the University of Washington, Seattle, by 
sequencing overlapping subclones with the ABI PrismTM Dye Termina- 
tor Cycle Sequencing Kit (Perkin Elmer) on an automated DNA 
sequencer, model ABI Prism 377 (Perkin Elmer). 
Computer analysis of DNA and protein sequences 
Sequences were analysed with the University of Wisconsin Genetics 
Computer Group programs and the DNASIS programs (Hitachi Software 
Engineering Co. Ltd., Japan). A version of the FRAME program [18], 
MacFRAME (version 1.2 developed by Kevin Kendall (Tulane University, 
New Orleans, LA), was used to identify potential protein-coding regions. 
Accession numbers 
The entire sequence reported here, together with revised versions of 
those previously submitted [12,1 71, have been deposited in the EMBL 
database under the accession number AJOll500. 
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